By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novartis Pharmaceuticals Canada Inc. 

385 Bouchard Boulevard

Dorval  Quebec  H9S 1A9  Canada
Phone: 514-631-6775 Fax:


SEARCH JOBS



Segment
Pharmaceuticals





Company News
Novartis Pharmaceuticals Canada Inc. (NVS) Announces Results At 2014 American Thoracic Society International Conference For Once Daily Dual Bronchodilator Ultibro┬« Breezhaler┬« Versus Combination Therapy For COPD 5/21/2014 6:23:46 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Bexsero®: First Vaccine To Prevent Meningococcal Serogroup B (MenB) Now Available In Canada 2/26/2014 11:44:25 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Receives Health Canada Approval For Ultibro ™ Breezhaler ®, A Once-Daily Dual Bronchodilator For COPD 1/14/2014 10:33:33 AM
Health Canada Approves Novartis Pharmaceuticals Canada Inc. (NVS)'s Bexsero*, The First Vaccine Available To Prevent Meningococcal Serogroup B (MenB)(1,2) 12/9/2013 7:01:39 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Release: New Study Confirms Seasonal Flu Vaccine Designed for Seniors Improved Protection Against Influenza? 11/5/2013 8:51:07 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Continues to Build Its COPD Pipeline and Presents New Data on Investigational Once-Daily QVA149 at ERS 9/9/2013 8:05:09 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Now Available in Ontario, (Pr)SEEBRI* BREEZHALER*, a Long-Term Once-Daily Maintenance Treatment for Chronic Obstructive Pulmonary Disease (COPD) 9/3/2013 10:09:22 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Resumes Seasonal Influenza Vaccine Distribution as Health Canada Lifts Suspension 11/1/2012 10:00:07 AM
Novartis Pharmaceuticals Canada Inc. (NVS) Release: Canadian Agency for Drugs and Technologies in Health (CADTH) Recommends Provincial and Publicly Funded Drug Plans Reimburse (Pr)Lucentis* to Treat Vision Loss Resulting From Diabetic Macular Edema (DME) 3/29/2012 9:43:37 AM
Health Canada Removes Novartis Pharmaceuticals Canada Inc. (NVS)'s Cox-2 Drug Prexige from the Market over Liver Problems 10/4/2007 1:21:42 PM
12
//-->